The future of tirzepatide and incretin based medication What makes Tirzepatide so exciting is that it paves the way forward for whats likely to be the next generation of drugs for type 2 diabetes and obesity
Unprecedented revenue growth: Ozempic and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide) have generated or are projected to generate far higher U.S
Clinical studies have demonstrated that GLP-1 drugs, including Ozempic, modulate stomach nerves, reducing muscle contractions during digestion
Its best to rotate these every week to help prevent inflammation, scarring or injection site reactions
For more persistent reflux, your GP may recommend: Proton pump inhibitors (PPIs) such as omeprazole or lansoprazole, which reduce stomach acid production and are the first-line treatment for GORD according to NICE guidance, typically for 4-8 weeks with review
The graph represents the percentage of patients with type 2 diabetes observed in England in year of 2024